Resistance prediction in AML: analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOG and MD Anderson Cancer Center-Reference-Cited by-同舟云学术

Resistance prediction in AML: analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOG and MD Anderson Cancer Center

Published:2014-08-12 Issue:2 Volume:29 Page:312-320
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Walter R B,Othus M,Burnett A K,Löwenberg B,Kantarjian H M,Ossenkoppele G J,Hills R K,Ravandi F,Pabst T,Evans A,Pierce S R,Vekemans M-C,Appelbaum F R,Estey E H

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2014242.pdf

Reference35 articles.

1. Estey E, Döhner H . Acute myeloid leukaemia. Lancet 2006; 368: 1894–1907.

2. Döhner H, Estey EH, Amadori S, Appelbaum FR, Büchner T, Burnett AK et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 2010; 115: 453–474.

3. Ferrara F, Schiffer CA . Acute myeloid leukaemia in adults. Lancet 2013; 381: 484–495.

4. Burnett AK, Russell NH, Hills RK, Hunter AE, Kjeldsen L, Yin J et al. Optimization of chemotherapy for younger patients with acute myeloid leukemia: results of the medical research council AML15 trial. J Clin Oncol 2013; 31: 3360–3368.

5. Kayser S, Zucknick M, Döhner K, Krauter J, Köhne CH, Horst HA et al. Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategies. Blood 2012; 119: 551–558.

Cited by 140 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Venetoclax-based treatment in acute myeloid leukemia: an unexpected bonus on the path to allogeneic hematopoietic stem cell transplant?;Leukemia & Lymphoma;2024-07-23

2. Sugar ring alignment and dynamics underline cytarabine and gemcitabine inhibition on Pol η catalyzed DNA synthesis;Journal of Biological Chemistry;2024-06

3. Stellae-123 gene expression signature improved risk stratification in Taiwanese acute myeloid leukemia patients;Scientific Reports;2024-05-14

4. Revumenib (SNDX-5613): a promising menin inhibitor for the management of relapsed and refractory acute myeloid leukaemia (AML);Annals of Medicine & Surgery;2024-03-18

5. Mutant U2AF1-Induced Mis-Splicing of mRNA Translation Genes Confers Resistance to Chemotherapy in Acute Myeloid Leukemia;Cancer Research;2024-02-28